Growth Metrics

Steris (STE) Cost of Revenue (2018 - 2025)

Steris has reported Cost of Revenue over the past 8 years, most recently at $840.7 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 10.59% year-over-year to $840.7 million; the TTM value through Dec 2025 reached $3.3 billion, up 6.67%, while the annual FY2025 figure was $3.1 billion, 4.66% up from the prior year.
  • Cost of Revenue for Q4 2025 was $840.7 million at Steris, up from $814.4 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $840.7 million in Q4 2025 and troughed at $493.7 million in Q1 2021.
  • A 5-year average of $700.7 million and a median of $711.9 million in 2021 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: soared 68.19% in 2021 and later dropped 15.07% in 2022.
  • Year by year, Cost of Revenue stood at $670.9 million in 2021, then dropped by 5.46% to $634.2 million in 2022, then rose by 16.31% to $737.7 million in 2023, then increased by 3.05% to $760.2 million in 2024, then grew by 10.59% to $840.7 million in 2025.
  • Business Quant data shows Cost of Revenue for STE at $840.7 million in Q4 2025, $814.4 million in Q3 2025, and $763.1 million in Q2 2025.